Low expression of miR-92b and miR-96 is associated with enhanced PRMT5 translation which is overexpressed in aggressive B-cell NHL, including MCL. Re-expression of miR-92b and miR-96 inhibits PRMT5 translation and alters the growth of MCL cells. The gene discussed is PRMT5; the disease is mantle cell lymphoma.